More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

October 22, 2024 Shannon Young, Associate Editor/Senior Writer Views

The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!